Nitro-oleic acid ameliorates oxygen and glucose deprivation/re-oxygenation triggered oxidative stress in renal tubular cells via activation of Nrf2 and suppression of NADPH oxidase

Abstract

Nitroalkene derivative of oleic acid (OA-NO), due to its ability to mediate revisable Michael addition, has been demonstrated to have various biological properties and become a therapeutic agent in various diseases. Though its antioxidant properties have been reported in different models of acute kidney injury (AKI), the mechanism by which OA-NO attenuates intracellular oxidative stress is not well investigated. Here, we elucidated the anti-oxidative mechanism of OA-NO in an in vitro model of renal ischemia/reperfusion (I/R) injury. Human tubular epithelial cells were subjected to oxygen and glucose deprivation/re-oxygenation (OGD/R) injury. Pretreatment with OA-NO (1.25 μM, 45 min) attenuated OGD/R triggered reactive oxygen species (ROS) generation and subsequent mitochondrial membrane potential disruption. This action was mediated via up-regulating endogenous antioxidant defense components including superoxide dismutase (SOD1), heme oxygenase 1 (HO-1), and γ-glutamyl cysteine ligase modulatory subunits (GCLM). Moreover, subcellular fractionation analyses demonstrated that OA-NO promoted nuclear translocation of nuclear factor-E2- related factor-2 (Nrf2) and Nrf2 siRNA partially abrogated these protective effects. In addition, OA-NO inhibited NADPH oxidase activation and NADPH oxidase 4 (NOX4), NADPH oxidase 2 (NOX2) and p22 up-regulation after OGD/R injury, which was not relevant to Nrf2. These results contribute to clarify that the mechanism of OA-NO reno-protection involves both inhibition of NADPH oxidase activity and induction of SOD1, Nrf2-dependent HO-1, and GCLM.

New Insights into the Anti‐Inflammatory and Antioxidant Properties of Nitrated Phospholipids

“…In our work, the amount of DPPH • radical consumed was 74 μmol DPPH • radical/g of nitrated POPC, within a similar order of magnitude. A very recent study also evaluated the antioxidant capability using the ABTS assay to corroborate that OLA‐NO 2 improved the cellular total antioxidant capacity in an in vitro model of renal ischemia/reperfusion injury using human tubular epithelial cells (HK‐2 cells) that were subjected to oxygen and glucose deprivation/reoxygenation injury (Nie et al, ).…”

Dexmedetomidine protects against oxygen-glucose deprivation/reoxygenation injury-induced apoptosis via the p38 MAPK/ERK signalling pathway

“…Oxygen-glucose deprivation/reoxygenation (OGD/R) injury is one of the critical pathological processes, which is involved in a series of ischaemic diseases, such as ischaemic heart disease, kidney ischaemic injury, and ischaemic stroke. 1 – 3 Currently, because of limited treatments for ischaemic diseases, many patients still suffer from mortality as well as a poor prognosis. 4 Although much progress has been made, understanding of the mechanisms involved in OGD/R injury remains largely limited.…”

Antioxidative and Antiapoptotic Effects of Delta-Opioid Peptide [D-Ala2, D-Leu5] Enkephalin on Spinal Cord Ischemia-Reperfusion Injury in Rabbits

“…Oxidative stress reaction is now believed to play a major role in the progression of several organ I/R injury such as brain (Liu et al, 2015b ), liver (Liu et al, 2014 ), and kidney (Nie et al, 2016 ), including spinal cord (Wang et al, 2017 ). During I/R, the oxidative processes resulting from the abundant free radicals may cause protein breakdown, lipid peroxidation and DNA damage.…”